This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy Policy.

logo.svg
About us
Company Overview
Leadership Team
History
Research and Development
Pipeline
Discovery Research
Clinical Development
Pharmaceutical R&D
Quality System
Investor Relationship
Partnering
News Release
Company News
Media Report
Industrial News
Careers
Contact us
中
f1_banpc.png
f1_banph.jpg

News Release

> News Release
> Company News
Company News
Media Report
Industrial News
logo2.jpg

Hope Medicine Announces US FDA Clearance for Phase II Clinical Trial of A First-in-class Monoclonal Antibody, HMI-115, in AGA Alopecia

MORE
f1_img2-868.png

Hope Medicine Inc. Announced Dr. Henri Nico Doods as Chief Executive Officer

MORE
xinwensuoluetu-979.jpg

Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation

MORE
1.jpg

Hope Medicine Inc. Announced Dr. Henri Nico Doods as President and Head of Research & Clinical Development

MORE
0408.jpg

Hope Medicine announced global license agreement with Bayer AG to advance the development and commercialization of the monoclonal antibody directed against prolactin (PRL) receptor

MORE

Follow Us

g_img1.png

Top